rs4880, SOD2

N. diseases: 131
Source: ALL
Disease N. SNPs d DSI v DPI v Chr Position Consequence Alleles Class AFEXOME AFGENOME Score vda EI vda N. PMIDs First Ref. Last Ref.
Xeroderma Pigmentosum, Complementation Group D
111 0.500 0.840 6 159692840 missense variant A/G snv 0.48 0.47 0.010 1.000 1 2014 2014
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding)
92 0.500 0.840 6 159692840 missense variant A/G snv 0.48 0.47 0.010 1.000 1 2013 2013
Vitiligo
CUI: C0042900
Disease: Vitiligo
249 0.500 0.840 6 159692840 missense variant A/G snv 0.48 0.47 0.010 1.000 1 2013 2013
Vaso-Occlusive Crisis
CUI: C0750151
Disease: Vaso-Occlusive Crisis
5 0.500 0.840 6 159692840 missense variant A/G snv 0.48 0.47 0.010 1.000 1 2018 2018
Vascular Diseases
CUI: C0042373
Disease: Vascular Diseases
40 0.500 0.840 6 159692840 missense variant A/G snv 0.48 0.47 0.010 1.000 1 2017 2017
Tumor Progression
CUI: C0178874
Disease: Tumor Progression
72 0.500 0.840 6 159692840 missense variant A/G snv 0.48 0.47 0.010 1.000 1 2012 2012
Tardive Dyskinesia
CUI: C0686347
Disease: Tardive Dyskinesia
67 0.500 0.840 6 159692840 missense variant A/G snv 0.48 0.47 0.020 0.500 2 2008 2010
Sudden sensorineural hearing loss
CUI: C4275242
Disease: Sudden sensorineural hearing loss
38 0.500 0.840 6 159692840 missense variant A/G snv 0.48 0.47 0.010 1.000 1 2012 2012
Stomach Carcinoma
CUI: C0699791
Disease: Stomach Carcinoma
652 0.500 0.840 6 159692840 missense variant A/G snv 0.48 0.47 0.020 1.000 2 2010 2010
Stage IV Prostate Carcinoma
CUI: C0278837
Disease: Stage IV Prostate Carcinoma
6 0.500 0.840 6 159692840 missense variant A/G snv 0.48 0.47 0.010 1.000 1 2015 2015
Stage IV Prostate Cancer AJCC v8
CUI: C4553752
Disease: Stage IV Prostate Cancer AJCC v8
6 0.500 0.840 6 159692840 missense variant A/G snv 0.48 0.47 0.010 1.000 1 2015 2015
Stage IV Prostate Cancer AJCC v7
CUI: C3146264
Disease: Stage IV Prostate Cancer AJCC v7
6 0.500 0.840 6 159692840 missense variant A/G snv 0.48 0.47 0.010 1.000 1 2015 2015
Sporadic Parkinson disease
CUI: C4511452
Disease: Sporadic Parkinson disease
65 0.500 0.840 6 159692840 missense variant A/G snv 0.48 0.47 0.010 1.000 1 2014 2014
Sleep attack
CUI: C0855247
Disease: Sleep attack
3 0.500 0.840 6 159692840 missense variant A/G snv 0.48 0.47 0.010 1.000 1 2019 2019
Septicemia
CUI: C0036690
Disease: Septicemia
141 0.500 0.840 6 159692840 missense variant A/G snv 0.48 0.47 0.010 1.000 1 2013 2013
Sepsis
CUI: C0243026
Disease: Sepsis
144 0.500 0.840 6 159692840 missense variant A/G snv 0.48 0.47 0.010 1.000 1 2013 2013
Seizures
CUI: C0036572
Disease: Seizures
553 0.500 0.840 6 159692840 missense variant A/G snv 0.48 0.47 0.010 1.000 1 2019 2019
Secondary malignant neoplasm of lymph node
188 0.500 0.840 6 159692840 missense variant A/G snv 0.48 0.47 0.010 1.000 1 2012 2012
Schizophrenia
CUI: C0036341
Disease: Schizophrenia
2897 0.500 0.840 6 159692840 missense variant A/G snv 0.48 0.47 0.010 1.000 1 2009 2009
Prostate carcinoma
CUI: C0600139
Disease: Prostate carcinoma
1168 0.500 0.840 6 159692840 missense variant A/G snv 0.48 0.47 0.100 0.857 14 2007 2016
Prostate Cancer, Hereditary, 7
CUI: C1853195
Disease: Prostate Cancer, Hereditary, 7
11 0.500 0.840 6 159692840 missense variant A/G snv 0.48 0.47 0.010 1.000 1 2015 2015
Primary malignant neoplasm of lung
CUI: C1306460
Disease: Primary malignant neoplasm of lung
981 0.500 0.840 6 159692840 missense variant A/G snv 0.48 0.47 0.080 0.875 8 2004 2017
Primary malignant neoplasm
CUI: C1306459
Disease: Primary malignant neoplasm
1374 0.500 0.840 6 159692840 missense variant A/G snv 0.48 0.47 0.030 1.000 3 2008 2015
Primary angle-closure glaucoma
CUI: C0017606
Disease: Primary angle-closure glaucoma
55 0.500 0.840 6 159692840 missense variant A/G snv 0.48 0.47 0.010 1.000 1 2015 2015
Precursor Cell Lymphoblastic Leukemia Lymphoma
168 0.500 0.840 6 159692840 missense variant A/G snv 0.48 0.47 0.010 1.000 1 2017 2017